Cambridge Investment Research Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPIX
BCM
BAM
Cambridge Investment Research Advisors's CPIX Position: Q4 2021 in Review
Cambridge Investment Research Advisors sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2021, closing a stake of 10,000 shares — an estimated $27K sold.
Cambridge Investment Research Advisors first reported a position in CPIX in Q2 2014 and held it in 30 quarters. The position peaked at $74K in Q4 2017. 26 funds tracked by Wall St. Rank hold CPIX as of Q4 2021.
- Cambridge Investment Research Advisors reported no remaining Cumberland Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 10,000 Cumberland Pharmaceuticals shares in Q4 2021, an estimated $27K.
- Cambridge Investment Research Advisors first reported a position in Cumberland Pharmaceuticals in Q2 2014 and held it in 30 quarters.
- Cambridge Investment Research Advisors's Cumberland Pharmaceuticals position peaked at $74K in Q4 2017.
- 26 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2021.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.